Product approvals

Explore the landscape of product approvals in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on product approvals to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Five Innovative Therapies Enter the Rare Disease R&D Pilot Initiative – Spanning Blau Syndrome, Angelman Syndrome, ALS and Charcot‑Marie‑Tooth Disease
Policy / Regulatory

Five Innovative Therapies Enter the Rare Disease R&D Pilot Initiative – Spanning Blau Syndrome, Angelman Syndrome, ALS and Charcot‑Marie‑Tooth Disease

Accropeutics, Anyea, Myrobalan Therapeutics and ReviR Therapeutics announced that AC‑101, ANY‑108, ANY‑112, MRO‑001HS and RTX‑117 have been admitted into the pilot initiative encouraging the research and development of innovative therapies…

Suzhou Rigerna Therapeutics' RG002C0106 Injection Supplemental Application Accepted by China's CDE – Class 1 Chemical Drug Enters Regulatory Review

Suzhou Rigerna Therapeutics’ RG002C0106 Injection Supplemental Application Accepted by China’s CDE – Class 1 Chemical Drug Enters Regulatory Review

Hyperway Pharmaceutical Closes Series B+ Financing Round – Penglai Private Fund and Hengdian Capital Back the Chengdu Biotech's CNS and Brain‑Penetrant Drug Pipeline

Hyperway Pharmaceutical Closes Series B+ Financing Round – Penglai Private Fund and Hengdian Capital Back the Chengdu Biotech’s CNS and Brain‑Penetrant Drug Pipeline

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Takeda’s Mobocertinib Approved in China for EGFR Exon20ins NSCLC

CompanyDrug

Pfizer’s Nurtec ODT Launches in China via Hainan’s Bo’Ao Lecheng Zone

CompanyDrug

Suzhou Thery’s Generic Nilotinib Approved by China’s NMPA

CompanyDrug

Hainan Poly Pharm’s Generic Ganciclovir Approved in Denmark

CompanyDrug

Eisai CEO Outlines Ambitions for Alzheimer’s Drug Leqembi After FDA Approval

CompanyDrug

Jiangsu Aidea’s ACC007 Approved by NMPA for HIV-1 Treatment

CompanyMedical Device

NMPA Approves Chinabridge’s ECMO Equipment for Emergency Use

CompanyDrug

Henlius’ Hanbeitai Gains NMPA Approval for Expanded Indications

Show More